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Abstract
Objective: Echocardiography is helpful in assessment of pulmonary hemodynamic, however its correlation with Right
heart catheterization (RHC) is conﬂicting. We conducted a study to evaluate sensitivity and speciﬁcity of pulmonary
hemodynamic parameters measured in echocardiography. Furthermore its correlation with the values measured in RHC
was assessed.
Method: Retrospective, cross-sectional study conducted at King Fahad medical City, Riyadh, Saudi Arabia. 95 adult
patients referred for right heart catheterization were enrolled in the study. All the patients had echocardiography and
RHC within one week of each other.
Result: Diabetes mellitus, hypertension and dyslipidemia were present among 55%, 66% and 41% of patients
respectively. 85% of the study participants were diagnosed to have pulmonary hypertension and 79% of the study
participants had postcapillary pulmonary hypertension. Sensitivity of pulmonary artery systolic pressure (PAPs), mean
pulmonary artery pressure (PAPm) using PAPs and pulmonary artery acceleration velocity (PAcT) were 86%, 93% and
89% respectively. Correlation of PAPs, PAPm using PAPs and PAcT on echo with invasive hemodynamic in RHC were
0.56, 0.43 and 0.24 respectively. Among patients with moderate to severe Tricuspid Regurgitation (TR) and tricuspid
annular plane systolic excursion (TAPSE) <1.5cm correlation of PAPs, PAPm using PAPs and PAcT on echocardiography
with right heart catheterization were 0.31, 0.24 and 0.42 respectively.
Conclusion: Echocardiographic assessment of PAPs and PAPm has high sensitivity and weak to moderate correlation
with hemodynamic data in RHC. PAPs measurement on echocardiogram has best correlation with invasive measurement
followed by PAPm measurement using PAPs. Among patients with moderate to severe TR and TAPSE <1.5cm PAPm
measurement using PAcT has better correlation than using PAPs.
Keywords: Pulmonary hypertension, Echocardiography, Right heart catheterization

1. Introduction

P

ulmonary hypertension (PH) is classiﬁed into
three categories depending upon severity [1]
and ﬁve categories [2] depending upon etiology.
Irrespective of the etiology it is associated with
poor prognosis and increase morbidity. Right

heart catheterization (RHC) is the standard of care
for the measurement of pulmonary pressures [2].
Invasive measurements require skill, appropriate
catheter, computer module, and critical care
setting or catheterization lab. These arrangements
are not present even at some secondary care
health facilities and in addition right heart
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catheterization is associated with morbidity of
1.1% and mortality of 0.05% [3]. Echocardiography (echo) is available at most places and can be
used for measurement of pulmonary artery systolic, diastolic, or mean pressures utilizing various
validated formulas [4]. Tricuspid regurgitation
(TR) velocity and Pulmonary artery acceleration
velocity (PAcT) were used in various formulas for
the estimation of pulmonary artery pressures [4].
Pulmonary artery systolic pressure (PAPs) or
mean pulmonary artery pressure (PAPm) in echo is
usually calculated by measuring tricuspid regurgitation peak velocity and using it in various validated
formulas. Pulmonary regurgitation velocity or pulmonary artery acceleration velocity measurements
can also be used for calculating systolic, diastolic, or
mean pulmonary artery pressures. Correlation of
PAPm derived by measuring TR peak velocity in
echo with measurements obtained in right heart
catheterization was documented in the literature
with conﬁlting accurasies. Measurement of pulmonary pressures using echo was found to have a good
correlation with the invasive measurement using
RHC in some studies [5,6], however, it was inaccurate in others [7e9].
This study was conducted to compare the pulmonary artery pressures (Systolic and Mean), cardiac out (CO) and pulmonary vascular resistance
(PVR) measured in right heart catheterization and
echocardiography to assess the accuracy and reliability of noninvasive measurements. PAPm in echo
was calculated by using two formulas. One formula
used PAPs derived from peak TR and other formula
utilized PAcT. Both the formulas were compared
with invasive measurement in right heart catheterization for correlation.

2. Patients and methods
This cross-sectional study was conducted at King
Fahad Medical City. King Fahad Medical City in
Riyadh is one of the largest and leading tertiary care
referral medical complexes in Saudi Arabia with a
total bed capacity of 1200. It was approved by the
IRB of King Fahad Medical City. All consecutive
adult patients undergoing right heart catheterization for evaluation of pulmonary hypertension at
King Fahad Medical City from January till
December 2019 were enrolled in the study. Patients
were required to give consent before the right heart
catheterization. Patients had echo within one week
before undergoing right heart catheterization and
most of the patients had 2 days before RHC. Echocardiogram was done by expert technicians and
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Abbreviations and acronyms
Echo
RHC
TR
PAcT
PAPs
PAPm
RAP
CO
PVR
PH
IVC
LVOT
PCWP
TAPSE
LVEDP

Echocardiography
Right heart catheterization
Tricuspid Regurgitation
Pulmonary artery acceleration time
Pulmonary artery systolic pressure
Mean pulmonary artery pressure
Right atrial pressure
Cardiac Output
Pulmonary vascular resistance
Pulmonary hypertension
Inferior VenaCava
Left Ventricle outﬂow tract
Pulmonary capillary wedge pressure
Trans Annular Plane Systolic Excursion
Left ventricle end diastolic pressure

read by two experienced echocardiologist. Right
heart catheterization was done by one cardiologist
experienced in performing the procedure. Patients
with congenital heart disease or intubated on mechanical ventilator were excluded from the study.
Demographic data, cardiovascular risk factors,
invasive and noninvasive hemodynamic parameters
were recorded and statistical tests were applied for
signiﬁcance and comparision.
Pulmonary Hypertension (PH) is deﬁne as
PAPm  25 mmHg measured during RHC [2]. On
echocardiography PAPs of 37 mmHg is suggestive
of PH with or without any additional echocardiographic feature of PH or PAPs <37 if any additional
feature of PH present in echocardiogram [2]. In our
study PAPs of 37 mmHg was considered as suggestive of PH. Right atrial pressure is estimated by
measuring inferior vena cava (IVC) and collapsibility
with breathing. IVC size of <2.1 cm and collapsibility
of >50% suggests right atrial pressure (RAP) of
3 mmHg, IVC size of >2.1 cm and collapsibility of
<50% suggest RAP of 13 mmHg and 8 mmHg is
suggested if IVC is > 2.1 cm with >50% collapsibility
or IVC is < 2.1 cm with collapsibility of <50% [2].
PAPm was calculated by two formulas in our study.
One formula used tricuspid valve regurgitation velocity [PAPm mmHg ¼ 0.6(PAPs) þ 2] [10] and other
formula used pulmonary artery acceleration time
(PAcT) [PAPm mmHg ¼ 79e0.45(PAcT)] [5]. CO in
RHC was measured using ﬁck formula [CO L/
min ¼ VO2/(SaO2 - SvO2) x Hb x 13.4] [11,12] and in
echo was measured using a formula incorporating
ﬂow across the Left ventricle outﬂow tract (LVOT)
[CO L/min ¼ Heart rate x 0.785 (diameter LVOT)2 x
VTI LVOT].
All adult patients aged >18 years undergoing
RHC from January 2019 till December 2019 were
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Table 1. Demographic and characteristics of study participants.
Characteristics of study participants

N ¼ 95

Age in years (mean)
Female
Diabetes
Hypertension
Dyslipidemia
Coronary artery disease
Smoking
LVEF  40%
LVEF 41%e49%
LVEF  50%
Hemoglobin (g/L)
Systolic Blood Pressure (mmHg)

54.6 ± 14.9 (18e87)
42 (44%)
52 (55%)
63 (66%)
36 (38%)
57 (60%)
44 (46%)
30 (32%)
7 (7%)
58 (61%)
12.18 ± 2.06
128.6 ± 23.8

included in the study. Patients were excluded if they
had congenital heart disease or echo was not done
within 1 week of right heart catheterization.
2.1. Statistical analysis
The data were entered into a database and
analyzed with the SPSS statistical software package
(SPSS v25.0 Chicago, Illinois, USA). The one-sample
KolmogoroveSmirnov test was used to test for
normality. A descriptive analysis was carried out in
which categorical variables were expressed as absolute and relative frequencies and continuous
variables as means (SD) or median with range.
Pearson chi-square test was used to compare proportions in independent groups. The Spearman
analysis was used to compare the correlation between two independent groups. A P-value of less
than 0.05 was considered to show a statistically
signiﬁcant difference. Sensitivity, speciﬁcity, accuracy, and positive and negative predictive values
were calculated using standard formulae. Pressures
and measurments gathered during RHC were

considered as gold standard and used as a reference
for calculation of sensitivity and speciﬁcity of measurement obtained in echocardiography. Correlation between the variables measured in echo and
RHC was carried out by using Spearman analysis.
In our study Correlation coefﬁcient ‘r’ between 0.2
and 0.39, 0.4e0.59, 0.6e0.79, and 0.8e1.0 are
considered weak, moderate, strong, and very strong
correlation respectively.

3. Results
There were 95 patients enrolled in the study. All
had RHC and echo within a week of each other.
These included 42 (44%) females and the mean age
of study participants was 54.6 ± 14.9 years. Diabetes
mellitus, hypertension, dyslipidemia, and coronary
artery disease were present in 55%, 66%, 41% and
62% of the patients respectively. Smoking was
prevalent among 46% of study participants. Left
ventricular ejection fraction (LVEF) was 50% in
61% of patients and Pulmonary hypertension (PH)
was present in 85% of study participants (Table 1).
Pulmonary capillary wedge pressure (PCWP) was
elevated among 83% of the patients and 79% of the
patients had post-capillary pulmonary hypertension
(Table 2).
The mean values of RHC variables are shown in
Table 2 and the mean values of echo variables are
given in Table 3. The mean values were comparable
for PAPs (60 mmHg) measured in RHC and echo,
and PAPm (40 mmHg) measured in RHC and echo
using PAPs).
The sensitivity of noninvasive PAPm detection
using formula [0.6(PAPs) þ2] was 94% with a positive predictive value of 88% and a positive likelihood ratio of 1.5 Table 4. The correlation with

Table 2. Mean values and percentages of variable among right heart catheterization (n ¼ 95).
Right heart catheterization parameters

Mean ± SD (min - max)

Right atrial Pressure (mmHg)
Pulmonary artery systolic pressure (mmHg)
Pulmonary artery diastolic pressure (mmHg)
Mean pulmonary artery pressure (mmHg)
Pulmonary Capillary Wedge Pressure (mmHg)
Cardiac Output (L/min)
Cardiac Index
Pulmonary Vascular Resistance (WU)
Pulmonary Vascular Resistance 3WU (WU)
Pulmonary Hypertension (mPAP 25 mmHg)
Elevated Pulmonary capillary Wedge Pressure (PCWP  15)
Post Capillary Pulmonary Hypertension (mPAP 25 mmHg, PCWP  15 mmHg)
Trans Pulmonary Gradient  12 mmHg
Diastolic Pulmonary Gradient  7 mmHg

15.5 ± 7.6 (2e37)
60.3 ± 22.2 (27e118)
26.0 ± 10.8
40.2 ± 14.2 (18e75)
22.9 ± 10.2 (7e59)
4.1 ± 1.1 (2.0e6.7)
2.27 ± 0.65 (1.15e3.90)
4.71 ± 3.55 (0.47e15.70)
58%
85%
89%
79%
68%
28%

Table 3. Percentage and mean values of the variable during echocardiography (n ¼ 79).
Echocardiographic Parameters

Mean ± SD (min e max)

Pulmonary artery systolic
pressure (4TR2þRAP) (mmHg)
Mean Pulmonary artery pressure
[0.6(PSAP)þ2] (mmHg)
Mean Pulmonary artery pressure
[79e0.45(AcT)] (mmHg)
Cardiac Output (L/min)
E/e’ ratio
Pulmonary Vascular Resistance
[{10(TRvel/PV VTI)þ0.16}/80]
(WU)
Mitral Regurgitation (III/IV)
Tricuspid Regurgitation (III/IV)
TAPSE < 1.7 cm
Pulmonary Vascular
Resistance  3WU

59.7 ± 21.4 (20e110)
37.6 ± 13.7 (14e71)
32.5 ± 13.5 (2.9e56.5)
3.9 ± 1.6 (1.1e7.48)
18 ± 8.6 (6e40)
4.50 ± 2.94 (1.25e15.7)

29/61
43/95
38/85
45/71

(48%)
(45%)
(45%)
(63%)

invasive measurement of PAPm was 0.43 suggestive
of a moderate degree of correlation (Fig. 2B). The
correlation (r ¼ 0.51) was better among patients with
trace to mild TR and TransAnnular Plane Systolic
Excursion (TAPSE)  1.5 cm compared to patients
with moderate to severe TR and TAPSE < 1.5 cm (r:
0.2) (Table 5). Noninvasive PAPm measured in echo
using PAPs was within 10 mmHg of the invasive

PAPm measured in RHC among 53% of the patients
(Fig. 1).
The sensitivity of noninvasive PAPm using formula [79e0.45(PAcT)] was 89% with a positive predictive value of 76% and a positive likelihood ratio
of 1.17 Table 4. Accuracy was 72% and correlation
with invasive measurement of PAPm was 0.29 suggestive of a weak correlation (Fig. 2C). Noninvasive
PAPm measured in echo using PAcT was within
10 mmHg of the invasive PAPm measured in RHC
among 39% of the patients (Fig. 1). There was a
moderate correlation (r: 0.42) among patients with
moderate to severe tricuspid regurgitation and
TAPSE < 1.5 cm (Table 5).
The sensitivity of noninvasive PAPs measured
using formula [4(TRmax)2þRAP] was 86% with a
positive predictive value of 89% and a positive
likelihood ratio of 1.48 Table 4. Accuracy was 79%
and correlation with invasive measurement of PAPs
was 0.56 suggestive of a moderate correlation
(Fig. 2A). The correlation further improved to strong
correlation (r ¼ 0.61) among patients with trace to
mild TR and TAPSE  1.5 cm (Table 5). Noninvasive
PAPs measured in echo was within 10 mmHg of the
invasive PAPs measured in RHC among 55% of the
patients (Fig. 1).

Table 4. Comparison and correlation of echocardiographic parameters with parameters in right heart catheterization (N ¼ 71).
Parameters in
Echocardiography

Comparison with parameters in right heart catheterization
Sens

Spec

PPV

NPV

PLR

NLR

Accu

r (P-Value)

Estimation of mPAP on
echocardiogram using
formula [0.6(PASP)þ2 ]
Estimation of mPAP on
echocardiogram using
formula [79
e0.45(PAcT)]
Estimation of PASP on
echocardiogram using
formula [4(TRmax)
2 þ RAP]
Estimation of CO on
echocardiogram using
formula [Heart rate x
0.785 (dimeter LVOT)2
 VTI LVOT]
Estimation of E/e’ on
echocardiogram and
correlation with PCWP
Estimation of PVR on
echocardiogram using
formula [{10(TRvel/PV
VTI)þ0.16}/80]

94%
(84.9e98.3)

38%
(13.8e92.1)

88%
(83.1e92.1)

55.5%
(27.9e80.1)

1.5
(0.9e2.3)

0.16
(.05e0.52)

84.6%
(74.6e91.7)

0.43
(<0.01)

89%
(78.4e96.0)

24%
(8.22e47.1)

76%
(71.1e80.4)

45.4%
(22.1e70.9)

1.17
(0.9e1.5)

0.44
(.15e1.3)

71.7%
(60.4e81.4)

0.29
(<0.01)

86%
(75.6e93.5)

42%
(15.1e72.3)

89%
(83.3e92.9)

35.7%
(18.3e57.8)

1.48
(0.9e2.4)

0.33
(.13e0.81)

79.4%
(68.8e87.8)

0.56
(<0.01)

63%
(45.9e78.1)

48%
(32e63.5)

52%
(42.8e61.4)

58.8%
(45.8e70.6)

1.21
(0.8e1.7)

0.77
(o.4e1.3)

55%
(43.4e66.1)

0.19
(0.10)

81%
(69.5e89.9)

28%
(9.6e53.4)

80%
(74.5e84.5)

29.4%
(14.4e50.6)

1.12
(0.8e1.5)

0.67
(0.2e1.6)

69.5%
(58.3e79.2)

0.29
(0.01)

75%
(60.6e85.4)

55.6%
(37.3e72.4)

73%
(59.0e84.0)

57.7%
(39.0e74.5)

1.69
(1.4e2.0)

0.45
(0.3e0.6)

67.6%
(56.1e77.3)

0.26
(0.02)

Sens: Sensitivity, Spec: Speciﬁcity, PPV: Positive Predictive Value, NPV: Negative Predictive Value, PLR: Positive likelihood Ratio, NLR:
Negative Likelihood Ratio, Accu: Accuracy, r: Spearman correlation coefﬁcient, mPAP: mean Pulmonary artery pressure, PASP: Pulmonary artery systolic pressure, RAP: Right atrial pressure, TRmax: Tricuspid regurgitation maximum, LVOT: Left ventricle outﬂow
tract, PCWP: Pulmonary capillary wedge pressure, PV: Pulmonary valve.
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Fig. 1. Proximity of noninvasive measurement with invasive measurement.

Pulmonary hypertension was conﬁrmed in RHC
among 94% of the patients who had PAPs
37 mmHg in echo. However, 61% of patients with
PAPs <37 mmHg in echo also had conﬁrmed PH in
RHC. Among patients with pulmonary hypertension conﬁrmed in RHC, 88% had PAPs 37 mmHg
in echo. 56% of patients with normal PA pressure in
RHC had PAPs <37 mmHg on echo.
The sensitivity of noninvasive CO measurement
using formula [Heart rate x 0.785 (dimeterLVOT)2 x VTI
LVOT] in echo was 63% with a positive predictive value
of 52% and a positive likelihood ratio of 1.21 Table 4.
Accuracy was 55% and correlation with invasive
measurement of CO was 0.19 suggestive of a weak
correlation (Fig. 2D). Among patients with moderate
to severe TR and TAPSE <1.5 cm correlation with
invasive measurements of CO became worse
(Table 5).
E/e’ ratio in echo of 10 cm/s was used as a
marker of elevated PCWP. The sensitivity of
noninvasive measurement of E/e’ ratio in echo for
detecting PCWP 15 mmHg was 81% with a positive predictive value of 80% and a positive likelihood ratio of 1.12 Table 4. Accuracy was 70% and
correlation with invasive measurement of PCWP
was 0.28 suggestive of a weak correlation (Fig. 2F).
Among patients with moderate to severe TR and
TAPSE <1.5 cm correlation improved to 0.5 suggestive of a moderate correlation (Table 5).
Echocardiographic measurement of PVR was
weakly correlated (r ¼ 0.26) with the measurement
of PVR in RHC (Fig. 2E). Among patients with
moderate to severe TR and TAPSE <1.5 cm correlation of measurement in echo with invasive measurement of PVR remained poor (Table 5).

4. Discussion
Echocardiography plays an important role in
assessing the probability of pulmonary hypertension and recommendations for further workup.
Tricuspid regugitaion velocity >2.8 and other
associated features such as right ventricle dilatation, ﬂattening of interventricular septum, dilatation of pulmonary artery, presence of pulmonary
regurgitation, increase pulmonary acceleration velocity, and dilatated and non-collapsing inferior
venacava suggest intermediate or high probability
of PH [2]. Most of the patients enrolled in our study
had high or intermediate probability of pulmonary
hypertension. In our study echo measurements of
PAPm using formulas incorporating PAPs or PAcT
were sensitive with high positive predictive value
(sensitivity 89e94% and PPV 76e88%). Higher
sensitivity in our study is in line with the previous
study [6] and suggests that echo is better at identifying PH among patients with PH. Good correlation was found between echo and RHC parameters
of PAPm and PAPs in a study conducted earlier
along with excellent sensitivity and speciﬁcity [6],
similarly, in our study 53% of the patients had
PAPm measured in echo using formula incorporating PAPs was within 10 mmHg of PAPm
measured in RHC and mean of both values were
also comparable. Conversely, lower speciﬁcity in
our study suggests that echo is not good at identifying individuals without PH. The absence of PH on
echocardiogram doesn't rule out PH and if clinically suggested then RHC should be requested.
According to a recent meta-analysis, pooled sensitivity and speciﬁcity of echo for diagnosis of PH
was 85% and 74% respectively [12]. Echo can't
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Fig. 2. Correlation of echocardiographic and right heart catheterization (RHC) parameter. A: Correlation between mean pulmonary artery pressure
(MPAP) in echo using PASP and RHC. B: Correlation between mean pulmonary artery pressure (MPAP) in echo using PAcT and RHC. C: Correlation
between pulmonary artery systolic pressure (PASP) in echo and RHC. D: Correlation between Cardiac Output (CO) in echo and RHC. E: Correlation
between pulmonary capillary wedge pressure (PCWP) in echo and Echo. F: Correlation between pulmonary vascular resistance (PVR) in echo and
RHC.

replace RHC which is considered as a gold standard [12]. Reveal registry concluded that echo had a
reasonable correlation with RHC at one time but
lack correlation in precise measurement of serial
changes in pulmonary hemodynamics [13]. In our
study echo had little impact on the pretest probability of PH. Our ﬁnding was in agreement with

another study suggesting an insufﬁcient role of
echo to rule out PH among patients with high
pretest probability [9].
Estimation of PAcT can be difﬁcult and subject to
error depending upon sampling site, RV function,
poor doppler signals, and heart rate. Among both
the formulas used for measurement of PAPm in our

Table 5. Correlation of echocardiographic parameters with right heart catheterization parameters among patients with right sided heart failure.
Echocardiographic variables

TR grade 3 or 4

Pulmonary artery systolic
pressure(PASP) (4TR2þRAP)
Mean Pulmonary artery
pressure(MPAP) [0.6(PSAP)þ2]
Mean Pulmonary artery
pressure(MPAP) [79e0.45(AcT)]
Pulmonary Vascular Resistance (PVR)
[{10(TRv/PV VTI)þ0.16}/80]
E/e’ ratio

Correlation
0.51
Correlation
0.22
Correlation
0.34
Correlation
0.37
Correlation
0.29
Correlation
0.05

Cardiac Output

TR grade 3 or 4
and TAPSE<1.5 cm

TR grade
1 or 2

with PASP on right heart catheterization
0.31
0.59
with MPAP on right heart catheterization
0.24
0.54
with MPAP on right heart catheterization
0.42
0.25
with PVR on right heart catheterization
0.35
0.23
with PCWP on right heart catheterization
0.57
0.32
with cardiac output on right heart catheterization
0.36
0.28

TR grade 1 or 2
and TAPSE 1.5 cm
0.61
0.54
0.26
0.17
0.28
0.24
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study, formula incorporating PAPs had a better
negative likelihood ratio (0.16 vs. 0.44), accuracy
(85% vs.72%), and correlation with invasive measurement (0.42 vs. 0.29) than formula utilizing PAcT.
Another study had also validated the formula
incorporating PAPs for calculating PAPm in echo [5]
and our study also suggested higher sensitivity and
accuracy for PAPm measurement using PAPs. In
our study among patients with moderate to severe
tricuspid regurgitation and TAPSE <1.5 cm, PAPm
measurement utilizing PAcT had a better correlation with invasive measurement and may be the
preferred method among such patients.
PAPs estimation by echo was sensitive with high
positive predictive value. Maximum tricuspid valve
regurgitation velocity is usually feasible for measurement and need to be assess in multiple views
for optimum value.
In our study, 88% of patients with PH (mean
PAP  25 mmHg in RHC) had PAPs 37 mmHg on
echo (True Positive) and 44% of patients with
normal PAP (mean PAP < 25 mmHg in RHC) had
PASP  37 mmHg on echo (false positive). The
ﬁndings in our study reiterate the ﬁnding of earlier
studies suggesting that absence or presence of pulmonary arterial systolic hypertension on echocardiogram doesn't rule out or rule in PH conclusively
and require invasive studies for further evaluation
among clinically indicated patients [9,14].
The modest correlation was found between invasive and echocardiographic assessment of PAPs
among the different subset of patients using higher
PAPs cutoff in echo [15,9]. In our study sensitivity
and speciﬁcity were 86% and 48% for the diagnosis
of PH at PAPs cutoff of 37 mmHg in echo and could
have been different if higher PASP cutoff was used.
In our study among all the echo variables studied,
PAPs measurement using tricuspid valve regurgitation has the best correlation and accuracy, 55% of
patients had differences between invasive and echo
reading of PAPs within 10 mmHg and mean values
measured by both modalities were also comparable.
Similarly to our study good sensitivity, speciﬁcity,
and correlation of PAPs measurement by echo was
noted in earlier studies [16,17], and in Reveal registry 43% of the patients had a difference of less than
10 mmHg in PAPs measured by echo and RHC [13].
In our study echo estimation of CO had the least
sensitivity, speciﬁcity, and correlation. Positive and
negative likelihood ratios were also close to 1 suggesting that it did not add much to the pretest
probability. Multiple factors were responsible for
low accuracy of noninvasive measurement of cardiac output. Measurement of LVOT is critical
because a minimal error will be duplicated and lead

to a huge difference [7]. Sampling of LVOT and
calculating Velocity time integral can also induce
errors. Our ﬁnding is similar to a previous study
stating inaccuracy in measuring cardiac output
using echocardiographic parameters [7].
Estimation of LVEDP (Left ventricle end diastolic
pressure) is critical in the management of patients with
heart failure and pulmonary hypertension. PCWP
measurement in RHC is a reliable estimation of
LVEDP and can be measured by placing a wedge
catheter in the pulmonary artery. Noninvasive measurement of E/e’ ratio by echo was found helpful for
estimating LVEDP. E/e’ ratio of <8 and >15 in echo is
suggestive of normal and abnormal LVEDP respectively [18,19]. Among patients with advanced systolic
heart failure, E/e’ showed poor correlation with
LVEDP especially in presence of resynchronization
therapy [20]. Cardiac resynchronization therapy has
effect on RV function and it was proposed to check
baseline RV function with stress test during preimplant evaluation, however cadidates shouldn't be denied of CRT based on RV function [21]. E/e’ ratio was
recommended to be supplemented by other echo parameters for proper estimation of LVEDP [22]. Quantitative PCWP in echo was measured using multiple
variables in a validated formula and showed good
correlation, sensitivity, and speciﬁcity when compared
with PCWP measurement in RHC [23]. In our study, E/
e’ of 10 cm/s in echo was 81% sensitive with PPV of
80% for the detection of PCWP 15 mmHg in RHC. E/
e’ in echo had a better correlation with invasive PCWP
measurement among patients with moderate to severe
TR and TAPSE <1.5 cm. E/e’ > 10 cm/s measured in
echo demonstrated good accuracy for detection of
PCWP >15 mmHg in RHC. However it lacked quantitative correlation with PCWP in RHC because E/e’ is
a echo variable which provides information regarding
left ventricle diastolic function, left ventricle end diastolic pressure, and PCWP instead of measuring the
PCWP itself. A study which measured PCWP using
echo variables showed good quantitative correlation
with PCWP measured in RHC [23].
Right heart disease is associated with a poor
correlation of PAPs measurement between echo
and RHC. Conversely, left heart pathology was
associated with higher correlation and less differences between echo and catheterization measurements [24]. In our study, 45% of the study
participants had evidence of right-sided dysfunction evident by reduced TAPSE and moderate to
severe TR. Right ventriculoarterial coupling
derived through variables measured in both RHC
and echo showed good correlation with right ventricular function [25]. A reduced TAPSE was positively
associated
with
impaired
right

ventriculoarterial coupling [25]. Correlation between echocardiographic and invasive measurement of PAPm using TR velocity and estimation of
CO became poor among patients with moderate to
severe tricuspid regurgitation and TAPSE <1.5 cm.
Echo measurement of PAPm using PAcT had a
better correlation with invasive measurement
among patients with moderate to severe TR and
TAPSE <1.5 cm and may be a preferred method
among such patients. The presence of a signiﬁcant
number of patients with right-sided dysfunction in
our study can explain the weak correlation found
between echo and right heart catheterization
assessment of pulmonary hypertension.
4.1. Strength and limitation
Echo and RHC were done within 1 week. Echo
was performed before the RHC. 36, 33, 11, 8 and 6
patients had echo 1, 2, 4, 5, and 6 days before RHC
respectively. Majority of the patients had echo
within 2 days of RHC and it is unlikely that clinical
condition would have changed drastically within 2
days to have a signiﬁcant impact on the result.
However, for our future studies will try to conduct
echo on the same day as of RHC to minimize the
chances of variation.
Chances of error in calculation of variables in
echo such as cardiac output, PAPm is high due to
complex formulas, difﬁcult windows and poor
Doppler signals. We minimized these errors by
using contrast when required, capturing multiple
views such as parasternal, long axis and nonstandard views according to the need, and
competent, well-trained staff performing and
reading the echoes.
We minimized the chances of error in measurement obtained in RHC by calculating during end
expiration and keeping zero reference line at the level
of mid thoracic line for best estimation of PCWP.

5. Conclusion
Echo parameters had high sensitivity for detecting pulmonary hypertension and estimating left
ventricular end-diastolic pressure. Among all the
echocardiographic variables measured in our
study estimation of pulmonary artery systolic
pressure has the highest correlation with right
heart catheterization measurement. Estimation of
mean pulmonary pressure in echo using tricuspid
valve regurgitation has a better correlation with
invasive measurements than using pulmonary artery acceleration time except among patients with
moderate to severe tricuspid regurgitation and
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TAPSE <1.5 cm. Noninvasive assessment of cardiac output using echo variables had the least
sensitivity. Invasive assessment of pulmonary hypertension is required among patients with
possible or deﬁnite pulmonary hypertension on
echocardiogram for further evaluation and
stratiﬁcation.
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